A data-driven investigation by Kaiser Health News revealed that spending on urine screens and related genetic tests quadrupled from 2011 to 2014 to an estimated $8.5 billion a year — more than the entire budget of the Environmental Protection Agency. Yet there are virtually no national standards regarding who gets tested, for which drugs and how often.